This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX World Congress

⏳ EARLYBIRD ENDS IN...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
29th-30th April 2024
Business Design CentreLondon
29th-30th April 2024
Business Design Centre,
London

Navigate the shifting biotech financing landscape by accessing strategic knowledge to simplify your route to capital and secure new partnerships

Connecting biotech leaders, investors, and large & midsize pharmaceutical companies

Biotech Leaders is part of LSX World

For the last 10 years, Biotech Leaders has been working with international life science & healthcare decision makers who are leading the next wave of industry innovation.

Our mission is to help them overcome challenges by connecting them with advisors and strategic partners that can help take their innovation from concept to market.

At the heart of the Biotech Leaders network are the founders and CEOs of the world’s most innovative drug discovery and therapeutic start-ups and SMEs. 

They are joined by leading health and life science investors from across Europe and the USA and pharma who are on the look out for new innovation, partners and advisors. 

Your conference toolkit to simplify your route to capital + new partners, across 3 dedicated tracks

CAPITAL MARKETS & INVESTMENT

Gain access to expert insights from some of the industry’s top investors to navigate the shifting biotech financing landscape.

 

Hear Monograph Capital, Kurma Partners, and Syncona speak to alternative sources of capital to effectively finance your business, understand strategies for success from EQT Life Sciences, ARCH Ventures Partners, and Angelini Ventures in approaching the right kinds of investors and building a stellar pitch, and investment trends on the horizon from Forbion, Gilde Healthcare, and RTW Investments.

PARTNERSHIPS & DEAL MAKING

Keep up to date with pharma partnering strategies and key therapeutic areas of interest to stay ahead of the competition amidst the looming patent cliff.

Be a part of the next wave of innovation and leverage the opportunity to hear AstraZeneca, GSK, J&J, and Ipsen share insight on how to strike your next oncology deal, how to secure unique partnering opportunities in the increasingly growing area of cardiovascular and metabolic diseases, and gain an understanding from Merck, Astellas, Novo Nordisk, and Novartis on how to form alternative types of deals to bring your pipelines to life and become a commercial-stage entity.

SCALING & COMMERCIALISATION

Look no further to find experienced biotech executives and leaders who have been there, done that, and have the battle scars to prove it.

 

Hear success stories from Genmab, BioNTech, Evotec, and Galapagos in scaling a global biotech, the role of business development in achieving nationwide reach through insights from Servier Monde, Lundbeck, and Debiopharm, how to executive a seamless early-commercial plan, and understand from discovery to launch the critical junctures biotech must prepare for before entering the market from Orchard Therapeutics, AM Pharma, and Calliditas Therapeutics.

5 Reasons to choose Biotech Leaders

Biotech Leaders @ LSX World Congress is Europe’s largest and most significant Biotech CEO gathering. No other event is exclusively designed to address all the strategic and partnering goals of Europe’s Biotech CEO ecosystem.

Biotech Leaders @ LSX World Congress attracts the highest quality speakers from the biggest and best large pharma and life science investment firms. Hear from global BD heads at GSK, Eli Lilly, Merck KGaA, Novartis, Novo Nordisk and top tier investment funds like Abingworth, Forbion, Sofinnova and SV Health Investors.

No other event offers access to as many highly-qualified, specialist life science investors. LSX World Congress will be bringing over 350 of the world’s most active investors to London. Fundraising? There’s no better place to be.

All biotechs, investors and pharma attendees are qualified during the registration process to ascertain their stage of development, strategic goals, therapeutic preferences, and fundraising/allocation targets. This provides absolute clarity on the issues that matter most to our attendees and allows delegates and partners to identify and target the most qualified prospects through our highly sophisticated 1-2-1 partnering system.


As well as partnering, content, showcases and exhibition, Biotech Leaders @ LSX World Congress offers a range of smaller group meetings/CEO forums/workshops targeting particular profiles of attendees. This means highly qualified groups of attendees to meet in an interactive and intimate setting and provides you with the opportunity to talk to the people that matter most to you.